Device Trial Radar · NCT07216599
Photoacoustic Imaging of Foot Wound
Last checked: Nov 19, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
25
Planned (sponsor's estimate)
Start
Oct 28, 2025
Primary completion
Apr 30, 2027
Study completion May 31, 2027
Sponsor
- Lead sponsor
- State University of New York at BuffaloAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Institute for Biomedical Imaging and Bioengineering (NIBIB)
- First posted
- Oct 14, 2025
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This pilot device trial aims to test the feasibility of using photoacoustic images to monitor tissue perfusion and to guide post-surgical wound treatment. Through this pilot study, the investigators will test the feasibility, identify any practical issues, and acquire essential information (e.g., drop-off rate, variation in wound healing rate) to guide future large-scale studies.
Conditions
- Foot Ulcer
Interventions
Photoacoustic imaging and multispectral imagingDevice
Use photoacoustic and Kent imaging devices that can image vasculature and assess tissue perfusion on the foot.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Treatment fidelity rateTime frame: 12 months
- Percentile healing scoreTime frame: 12 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
UBMD Vascular Surgery
Buffalo, New York · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.